• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, December 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Paris will host the 9th Annual Meeting of the International Society of Microbiota dedicated to microbiota and microbiotal medicine: Where we are now and what’s next?

Bioengineer by Bioengineer
October 4, 2022
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The International Society of Microbiota (ISM) will hold its 9th Annual Meeting in Paris, France & Online, from the 19th to the 21st of October, 2022.

International Society of Microbiota

Credit: Credits to the International Society of Microbiota

The International Society of Microbiota (ISM) will hold its 9th Annual Meeting in Paris, France & Online, from the 19th to the 21st of October, 2022.

Targeting Microbiota 2022 will highlight the following topics : Microbiota dysbiosis, Oral microbiota, Vaginal microbiota, Microbiota biofilms, Retinal disorders, Respiratory infections, Arterial thrombosis, Ischemic stroke, Ageing, Circadian system, Depression, FMT, Multi-omics, Gene editing, Precision medicine, Cancer immunotherapy, Mineral water, Mediterranean diet, Weight loss, and more…

The chairmen of the scientific committee, Peter C. Konturek and Marvin Edeas, will introduce a new way of thinking about the medicine of tomorrow. They will initiate the reflection and discussion about strategies that will allow us to accelerate Microbiota medicine applications.

More about the speakers.

To access the Congress Agenda.

Who’s Attending Targeting Microbiota 2022?

More than 34 countries will take part in Targeting Microbiota 2022, please click here to see who’s attending.

Among Targeting Microbiota 2022 Supporters: CosmosID and BIOMES.

About the International Society of Microbiota (ISM):

ISM was born in 2013 after the transformation of the Task Force Mitochondria-Microbiota to a larger group gathering all actors and experts working in the field of microbiota. The idea is to bring a new level of thinking and understanding of microbiota science out of the classical existing point of view. The science of gut and microbiota is a dynamic field, with a huge evolution and affected by multi factors. ISM will bring this new dynamic point of view to accelerate the credible translation of this science into real benefit for the consumer. ISM also encourages the communication and interaction among researchers, physicians, nutritionists, industrials, food technology and strategic marketing managers through a global microbiota network, especially during its annual world meeting.

For more news about ISM’s Annual meeting, follow us on :

Website | LinkedIn | Facebook



Share12Tweet8Share2ShareShareShare2

Related Posts

Mutated protein associated to recycling regulation

Leukemia cells activate cellular recycling program

December 4, 2023
Highly aggressive cell carcinomas

Mathematics supporting fresh theoretical approach in oncology

December 4, 2023

Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach

December 4, 2023

Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

December 4, 2023

POPULAR NEWS

  • Figure 1

    Understanding rapid tendon regeneration in newts may one day help human athletes

    85 shares
    Share 34 Tweet 21
  • Study finds increasingly popular oral nicotine pouches do little to curb smokers’ cravings

    35 shares
    Share 14 Tweet 9
  • SMART researchers pioneer novel microfluidic method to optimise bone marrow stem cell extraction for advanced cell therapies

    34 shares
    Share 14 Tweet 9
  • UMass Amherst receives $2.5 million from Howard Hughes Medical Institute to reshape STEM education

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Leukemia cells activate cellular recycling program

Mathematics supporting fresh theoretical approach in oncology

Georgia State professor granted $5 million to identify and characterize objects in space

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 58 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In